IL47334A - Pharmaceutical compositions for the treatment of parkinsonism, comprising l-dopa and cyproheptadine and their preparation - Google Patents
Pharmaceutical compositions for the treatment of parkinsonism, comprising l-dopa and cyproheptadine and their preparationInfo
- Publication number
- IL47334A IL47334A IL47334A IL4733475A IL47334A IL 47334 A IL47334 A IL 47334A IL 47334 A IL47334 A IL 47334A IL 4733475 A IL4733475 A IL 4733475A IL 47334 A IL47334 A IL 47334A
- Authority
- IL
- Israel
- Prior art keywords
- cyproheptadine
- parkinsonism
- dopa
- preparation
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HUEE2244A HU169186B (ja) | 1974-06-13 | 1974-06-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL47334A0 IL47334A0 (en) | 1975-07-28 |
IL47334A true IL47334A (en) | 1978-07-31 |
Family
ID=10995560
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL47334A IL47334A (en) | 1974-06-13 | 1975-05-21 | Pharmaceutical compositions for the treatment of parkinsonism, comprising l-dopa and cyproheptadine and their preparation |
Country Status (9)
Country | Link |
---|---|
US (1) | US3988461A (ja) |
JP (1) | JPS5112935A (ja) |
BE (1) | BE830238A (ja) |
DE (1) | DE2525064C2 (ja) |
FR (1) | FR2274291A1 (ja) |
GB (1) | GB1467117A (ja) |
HU (1) | HU169186B (ja) |
IL (1) | IL47334A (ja) |
ZA (1) | ZA753266B (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4131675A (en) * | 1978-02-09 | 1978-12-26 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. | Use of combinations of L-DOPA with trazodone and L-DOPA with etoperidone in Parkinsonism |
EP1732549A4 (en) * | 2004-03-18 | 2009-11-11 | Brigham & Womens Hospital | METHOD FOR THE TREATMENT OF SYNUCLEINOPATHIES |
WO2007075923A2 (en) * | 2005-12-23 | 2007-07-05 | Link Medicine Corporation | Treatment of synucleinopathies |
WO2009151683A2 (en) | 2008-03-12 | 2009-12-17 | Link Medicine Corporation | Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications |
EP2358370A2 (en) * | 2008-11-13 | 2011-08-24 | Link Medicine Corporation | Treatment of proteinopathies using a farnesyl transferase inhibitor |
AU2009313927A1 (en) | 2008-11-13 | 2010-05-20 | Astrazeneca Ab | Azaquinolinone derivatives and uses thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3014911A (en) * | 1958-09-29 | 1961-12-26 | Merck & Co Inc | Derivatives of dibenzo[a, e]cycloheptatriene |
AT314077B (de) * | 1972-01-07 | 1974-03-25 | Hurka Wilhelm | Verfahren zur Herstellung eines neuen, gegen den Parkinsonismus wirksamen Kombinationspräparates |
-
1974
- 1974-06-13 HU HUEE2244A patent/HU169186B/hu unknown
-
1975
- 1975-05-20 ZA ZA00753266A patent/ZA753266B/xx unknown
- 1975-05-21 IL IL47334A patent/IL47334A/xx unknown
- 1975-05-23 GB GB2254775A patent/GB1467117A/en not_active Expired
- 1975-06-05 DE DE2525064A patent/DE2525064C2/de not_active Expired
- 1975-06-05 US US05/583,904 patent/US3988461A/en not_active Expired - Lifetime
- 1975-06-11 FR FR7518234A patent/FR2274291A1/fr active Granted
- 1975-06-12 JP JP50071405A patent/JPS5112935A/ja active Pending
- 1975-06-13 BE BE157332A patent/BE830238A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BE830238A (fr) | 1975-10-01 |
FR2274291B1 (ja) | 1979-08-17 |
DE2525064C2 (de) | 1983-11-24 |
US3988461A (en) | 1976-10-26 |
DE2525064A1 (de) | 1976-01-02 |
FR2274291A1 (fr) | 1976-01-09 |
IL47334A0 (en) | 1975-07-28 |
ZA753266B (en) | 1976-04-28 |
HU169186B (ja) | 1976-10-28 |
JPS5112935A (ja) | 1976-01-31 |
GB1467117A (en) | 1977-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL48642A (en) | 3-amino-indazolecarboxylic acid derivatives,ther preparation and pharmaceutical compositions containing them | |
IL46967A (en) | N-pyrrolidyl-, n-piperidyl-,n-pyridyl-and n-pyrroly-polyfluoroalkyl-benzamide derivatives, their preparation and pharmaceutical compositions comprising them | |
IL48704A0 (en) | Azolyl-(1)-methanes and their salts,their preparation and pharmaceutical compositions containing them | |
IL48593A (en) | 1-substituted-4-benzylidenepiperidine derivatives, their preparation and pharmaceutical compositions comprising them | |
IL46695A (en) | Substituted n-(1-benzylpyrrolidinyl-2-alkyl)-benzamides, their preparation and pharmaceutical compositions containing them | |
IL47360A0 (en) | Cephalosporins,their preparation and pharmaceutical compositions containing them | |
IL46959A0 (en) | 1,1-diaryl-1-oxadiazolyl-alkylamines,their preparation and pharmaceutical compositions containing them | |
IL47529A0 (en) | New benzimidazolinone derivatives,their preparation and pharmaceutical compositions containing them | |
IL50618A0 (en) | Clavulanic acid amines,their preparation and pharmaceutical compositions containing them | |
IL47205A0 (en) | Watersoluble extracts,their preparation and pharmaceutical compositions containing them | |
IL48061A (en) | 4a-phenyl-cis-decahydroisoquinoline derivatives, their preparation and pharmaceutical compositions containing them | |
IL47329A0 (en) | New pyridobenzodiazepinones,their preparation and pharmaceutical compositions containing them | |
IL47015A (en) | Derivatives of phenthylamino-ketones and phenthylamino-dioxolanes,their preparation and pharmaceutical compositions containing them | |
IL46631A0 (en) | New cephalosporins,their preparation and pharmaceutical compositions containing them | |
PH13199A (en) | Methods and pharmaceutical preparation for the treatment of hypercholesterolaenia | |
IL47149A0 (en) | New amino acid derivatives,their preparation and pharmaceutical compositions containing them | |
KE2900A (en) | N-(1-benzylpiperid-4-yl)-benzamides, methods for their preparation and pharmaceutical compositions containing them | |
IL47334A (en) | Pharmaceutical compositions for the treatment of parkinsonism, comprising l-dopa and cyproheptadine and their preparation | |
IL46725A0 (en) | Derivative of gentamine and its salts,process of preparation and pharmaceutical compositions | |
IL47590A0 (en) | Vincaminic acid amides,their preparation and pharmaceutical compositions containing them | |
IL49991A (en) | L-pyroglutamyl-l-prolinamide, its preparation and pharmaceutical compositions containing it | |
IL47196A (en) | 7-substituted-8-aminomethyl-isoflavone derivatives, their preparation and pharmaceutical compositions containing them | |
HK20881A (en) | Cinnamamides,their preparation and pharmaceutical compositions containing them | |
IL47299A (en) | 3-thiomethyl-3-cephem-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
IL46476A0 (en) | 2-substituted 4,5-diphenylthiazoles,their preparation and pharmaceutical compositions containing them |